Marksans Pharma Ltd.

==> picture [191 x 49] intentionally omitted <==

----- Start of picture text ----- ••Marksans Pharma Ltd.----- End of picture text -----

BSELimited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 40000l. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

Dear Sirs,

Sub: Proceedings of the 28[th] Annual General Meeting of Marksans Pharma Limited held on Tuesday, September 29, 2020 at 11:00 AM through Video Conferencing.

This is to inform you that the 28[th] Annual General Meeting ("AGM") of Marksans Pharma Limited (lithe Company") was held today Le. Tuesday, September 29, 2020 at 11:00 AM through Video Conferencing and the businesses mentioned in the Notice dated August 4, 2020 were transacted.

Summary of proceedings under Regulation 30, Part-A of Schedule-III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is given below:

1. Date, Time and Venue of the Meeting:

The AGM of the Members of the Company was held on Tuesday, September 29, 2020 at 11:00 a.m. through Video Conferencing.

Brief details of the items deliberated at the meeting and the results thereof:
- a. Mr. Mark Saldanha, Chairman chaired the proceedings of the meeting.
- b. Mr. Harshavardhan Panigrahi, Company Secretary explained the procedure for conducting the meeting through Video Conferencing as well as voting during the AGM.
- d. The Chairman informed that all the Directors of the Company, Chief Financial Officer had joined the meeting from their respective locations. The Chairman further informed that Mr. Digant Parikh, Chairman of the Audit Committee and Mr. S. R. Buddharaju, Chairman of the Stakeholder Relationship Committee and the Nomination and Remuneration Committee attended the AGM from their respective locations. The Chairman further informed that representative of Statutory Auditor and Secretarial Auditor and Scrutinizer had also joined the meeting from their respective locations. 0.. ,f 1 . M! (jLU!lJ

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: [email protected] www.marksanspharma.com

·4· Marksans Pharma Ltd.

e. The Chairman informed that Due to the social distancing norms and in order to ensure safety of the Members and employees of the Company during the times of COVID-19 pandemic, the AGM was being held through virtual mode.
g. The following items of Ordinary and Special business as per the Notice of AGM dated August 4, 2020, were transacted at the meeting:
- Consideration and adoption of the Standalone and Consolidated Audited Financial Statements of the Company for the financial year ended 31[st] March, 2020 together with the reports of the Board of Directors' and the Auditors' thereon.
- Declaration of dividend of Rs. 0.10 (i.e. 10%) on Equity Shares of Re. 1/- each face value and dividend of Rs. 7.00 (i.e. 7%) on Redeemable Cumulative Preference Shares of Rs. 100/- each face value for the financial year ended March 31, 2020.
- • Re-appointment of Mrs. Sandra Saldanha (DIN: 00021023), who retired by rotation and being eligible, offered herself for re-appointment.
- Approval of appointment of and Remuneration to Mr. Varddhman Vikramaditya Jain (DIN: 08338573) as a Whole-time Director ofthe Company.
- Appointment of Mr. Varddhman Vikramaditya Jain (DIN: 08338573) as a Director liable to retire by rotation.
- Re-appointment of Mr. Seetharama Raju Buddharaju (DIN: 03630668) as an Independent Director of the Company not liable to retire by rotation.
- • Approval of re-appointment of and remuneration to Mr. Mark Saldanha (DIN: 00020983) as the Managing Director of the Company.
- Approval of re-appointment of and remuneration to Mrs. Sandra Saldanha (DIN: 00021023) as a Whole-time Director.
- Approval of Marksans Employees Stock Option Scheme 2020.

h. The Company Secretary informed that Members who did not vote earlier through remote e-voting may vote electronically during the course of the meeting.

Marksans Pharma Ltd.

" 11th Floor, GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: [email protected] www.marksanspharma.com

==> picture [191 x 48] intentionally omitted <==

----- Start of picture text ----- ••Marksans Pharma Ltd.----- End of picture text -----

i. The Company Secretary informed that the Board had appointed Mr. Jinesh Dedhia, Practicing Company Secretary, to act as the Scrutinizer to scrutinize the remote e-voting and the votes cast at the meeting in a fair and transparent manner and provide a consolidated report.
j. The Company Secretary then called the names of those Shareholders who had registered themselves to speak or ask questions pertaining to the performance of the Company during the Financial Year 2019-20, one by one.
k. Clarifications were provided by the Chairman to the queries raised by the members at the meeting.
I. The Company Secretary informed that results of voting would be announced on or before Thursday, 1[st] October, 2020 by intimation to the Stock Exchanges and would also be placed on the website of the Company www.marksanspharma.com.

3. Manner of approval:

Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the Listing Regulations, the Company had provided remote e-voting facility to its members to cast votes electronically, on all the resolutions set out in the notice.
Further, the facility for remote e-voting was also made available during the AGM to the members who were present at the AGM and had not cast their votes by remote e- voting earlier .

.4. The meeting concluded at 11:42 a.m. on the same day.

You are requested to take note ofthe same.

Yours faithfully, For if Marksans Pharma '1Ii-:Limited OJ)M

Harshavardhan Panigrahi Company Secretary